peroxisome have little activity (4) (5) (6) (7) (8) (9) . When patients with Zellweger syndrome and hyperpipecolic acidemia were given oral loading doses of pipecolic acid, their serum pipecolic acid levels were elevated for a prolonged period of time relative to controls (10) (11) (12) (13) (14) . In earlier studies, we found that L-pipecolic acid is oxidized in the peroxisome in the cynomolgus monkey (1 5) and in the mitochondrion in the rabbit (1 6). If the peroxisome is also the site of L-pipecolic acid oxidation in humans, this activity may be lost in Zellweger syndrome and the other peroxisomal disorders. These present experiments with human liver demonstrate that I ) the L-[~H] pipecolic acid oxidation assay previously developed for cynomolgus monkey tissues can be applied to postmortem human liver (15, 16) ; 2) L-pipecolic acid is oxidized to AAA in the peroxisome in humans, as in the monkey; and 3) the liver of infants with Zellweger syndrome oxidizes L-pipecolic acid abnormally. Substrate preparation. DL-[2,3,4,5,6-3H]Pipecolic acid ( 1 9 Ci/ mmol) was adjusted to a sp act of 500 mCi/mmol with cold Lpipecolic acid. To produce the L-enantiomer, the racemic compound was treated with D-amino acid oxidase and sodium borohydride as described by Chang et al. (method Bb;l? ). This treatment quantitatively converts the D-enantiomer to the Lenantiomer by repeated oxidation of D-pipecolic acid to A'-piperideine-2-carboxylic acid, which is then reduced by borohydride to DL-pipecolic acid (1 7). In each cycle of this reaction, the quantity of p pipec colic acid is reduced by 50%. The L-[2,3,4,5,6-3H]pipecolic acid was separated from reaction side products by elution from a 50 x 0.9-cm Ag 50 x 8 (200-400 mesh; Na' form) column with Pico IIB buffer at 52°C; fractions (1.0 mL) were collected. The purified [3H]pipecolic acid fraction was desalted on a 35 x 2.0-cm Dowex 50 X 8 (100-200 mesh; H' form) column using a 400 mL water wash, followed by elution of the L-[3H]pipecolic acid with approximately 600 mL of I-N NH40H. The purified radioactive substrate was dried in a rotary evaporator and reconstituted in deionized water.
MATERIALS AND METHODS

Materials
Tissue preparations. All liver specimens were obtained at autopsy. Liver samples from infants and children with Zellweger syndrome and X-linked adrenoleukodystrophy were provided by Drs. H.W. Moser, D. M. Danks, and A. Poulos. C. Rebouche (University of Iowa, Iowa City, IA) supplied infant control liver specimens, and three of the adult control livers were supplied by Dr. T. Tephly (University of Iowa, Iowa City, IA). The remaining tissues were obtained from our laboratory. All postmortem liver specimens were obtained at necropsy and frozen at -70 to -90°C until assay. The fresh liver sample used in the fractionation studies was obtained during organ harvest for transplantation. Organelles from this tissue were separated on Percoll gradients before freezing.
For postnuclear supernatants, 0.5 to 1.5 g of frozen liver was minced in about 3 vol of buffer (100-mM KC1, 50-mM Tris, pH 8.33, I-mM EGTA). To avoid activity losses from organelles broken by freezing, tissues were not rinsed with buffer, but were homogenized by four to five passes using a Potter-Elvehjem homogenizer with Teflon pestle and centrifuged for 30 s at 3900 x g. The supernatant was used in L-pipecolic acid oxidation assays.
To prepare peroxisome-enriched fractions, a 10% (wt/vol) suspension of minced fresh human liver in 250-mM sucrose, 5-mM HEPES, pH 7.5, I-mM EGTA was disrupted with one to two passes of a Potter-Elvehjem homogenizer. Heavy (M, mitochondria-enriched) and light mitochondrial (L, peroxisome-enriched) fractions were made by a modification of the method of DeDuve (1 8), by sedimenting the heavy mitochondrial fraction at 3650 x g for 10 min. This empirical modification improved the separation of human peroxisomes from mitochondria. The heavy or light mitochondrial pellets were resuspended in gradient buffer (250-mM sucrose, 2-mM MOPS, pH 7.2, 1-mM EGTA (2); 420 pL/g \vet tissue wt). For the gradient, 1 mL (20-30 mg protein) of the light mitochondrial suspension was layered on 20 mL of a 36.5% Percoll solution (7 mL isosmotic Percoll and 13 mL gradient buffer). The gradients self-formed in a 60Ti rotor during ultracentrifugation at 62 000 x g for 30 min. Gradients were separated into 2 mL fractions by mechanically pumping from the bottom of the tube.
Assays. L-Pipecolic acid oxidation was assayed as in the cynomolgus monkey (15) . The tissue preparation was combined with 60-pM L-[2,3,4,5,6-3H]pipecolic acid (500 mCi/mmol), 100-pM FAD, 1-mM NAD+, 5-mM KC1, 12-mM Tris, pH 8.3, and 0.1-mM EGTA in a final vol of 60 pL and incubated in a rotary shaking water bath at 37°C for 60 min. Samples were then immediately applied to sequential anion exchange-cation exchange columns with 250 pL of Ag 1 X 8 (100-200 mesh; acetate form) in the upper column and 250 pL of Dowex 50 x 8 (100-200 mesh; Hf form) in the lower column. Both columns were first eluted with 2.5 mL of water to recover the 3H20 produced by the reaction. AAA was eluted quantitatively from the anion exchange column with 1.5 mL of 1-N acetic acid. The L-[~H] pipecolic acid substrate bound exclusively to the cation exchange column and represented >99% of the total radioactivity on this column. In all experiments, less than 0.5% of the substrate L -~H -pipecolic acid was converted to 3H-AAA, and no other major radioactive products were detected (data available upon request). In addition, the peroxisome enriched light mitochondrial fraction from a fresh human liver sample was assayed using the method optimized for our rabbit mitochondrial studies (16) ; the pellet, suspended in 50-mM KCI, 25-mM HEPES, pH 7.5, 0.5-mM EGTA, 1.0-mM ATP, 2.5-mM MgC12, and 10% (vol/vol) glycerol, was incubated with 60-pM L-[2,3,4,5,6-3H]pipecolic acid (500 mCi/mmol), 100-pM FAD, and 1-mM phenazine ethosulfate. The remaining incubation and separation conditions were identical to those in the standard assay described above. 3H-AAA formation was linear with respect to time and protein under standard assay conditions (data not shown). For postnuclear supernatants, the reported values are the mean of triplicate determinations; the other assays were performed in duplicate. Results are reported as pmol AAA formed/mg protein/h. HzOz formation was determined by a modification of the method of Duley and Holmes (19) , which couples hydrogen peroxide production from oxidase reactions to the oxidation of o-dianisidine catalyzed by horseradish peroxidase. The reaction mixture contained, in 1-mL vol, 320 pM o-dianisidine-2 HC1, 30-mM Tris, pH 8.5, 80-mM KCl, 0.8-mM EGTA, postnuclear supernatants (1-1.5 mg protein), 10-mM L-pipecolic acid, and 1.8 U of horseradish peroxidase (Sigma Type VI). The L-pipecolic acid was omitted in blanks. The reaction was initiated by addition of L-pipecolic acid and was followed by monitoring the linear change in absorption at 460 nm (~4 6 " = 1 1.3 X lo3 M-'cm-' for oxidized o-dianisidine) at 37°C from 30 to 60 min. The reaction was linear with respect to added protein over this time interval. Omitting either L-pipecolic acid or peroxidase suppressed completely o-dianisidine oxidation.
Protein concentration was determined fluorometrically (20) . Glutamate dehydrogenase, a mitochondrial matrix marker en-. zyme, was assayed by the method of Strecker (21); catalase, a peroxisomal marker enzyme, by the method of Aebi (22); ancl aryl esterase, a microsomal marker, by the method of Beaufay et al. (23) . Student's t test was the only statistical test used. All y values are 1-tailed, and variation is expressed as SEM.
Amino acid analysis. A light mitochondrial fraction from fresh liver and a buffer blank were assayed for L-[3H]pipecolic acid oxidation as described under "Assays." The anion exchange eluates were lyophilized, dissolved in Beckman Li-S sample buffer, and the sample injected onto a 0.24-x 30-cm Beckman AA-10 column in a Beckman 121 MB Amino Acid Analyzer. Samples were analyzed on the Physiological Fluids Analysis, Single Column Lithium Program.
RESULTS
Characteristics of L-pipecolic acid oxidation in human liver. We performed amino acid analysis of the acidic products of Lpipecolic acid oxidation in a peroxisome-enriched human liver light mitochondrial fraction. A single peak coeluted with authentic a-aminoadipic acid and contained 88% of the total radioactivity applied to the column; a buffer blank had no radioactivity under the AAA peak (data not shown). When a combined light and heavy mitochondrial fraction from human liver was fractionated on a Percoll gradient, L-pipecolic acid oxidation activity most closely paralleled that of catalase, a peroxisomal marker, and not those of either esterase, a microsomal marker, or glutamate dehydrogenase, a mitochondrial marker (Fig. 1) . We recovered 50% of L-pipecolic acid oxidation activity from the gradient, comparable to that from monkey liver Percoll gradients (Mihalik SJ, Rhead WJ, unpublished observations). Recoveries of marker enzyme activities from the gradient ranged from 93 to 116%.
To determine the assay suitable for human tissues, activit:~ in a peroxisome-enriched human liver fraction was compared u1 ing two different assay systems, optimized for either rabbit n,itochondrial or monkey peroxisomal L-pipecolic acid oxidation (1 5, 16) . Sp act was 6-fold greater with the peroxisomal assay system than with the mitochondrial system (675 versus 1 17 pmol AAA/ mg protein/h). A mitochondria-enriched human liver fraction was assayed at both pH 7.5 and 8.5 with and without added antimycin A (100 pg/mL) and rotenone (25 pM). L-Pipecolic acid oxidation was not inhibited, also suggesting this activity is not mitochondrial (108% of control; data not shown). In the peroxisome-enriched light mitochondrial fractions' sp act was 15-fold greater than that in the postnuclear supernatant (44 pmol/mg proteinlh). Upon spectrophotometric assay with odianisidine as a chromophore and L-pipecolic acid as a substrate, human liver post nuclear supernatants formed H202 as a reaction product (106 + 13 pmol/mg protein/min; n = 3), suggesting involvement of an oxidase. In the cynomolgus monkey, this membrane-associated activity is peroxisomal and has been extensively purified (Ref. 16 i X-ALD = X-linked adrenoleukodystrophy.
$ ZS = Zellweger syndrome. p < 0.00 1 for ZS patients when compared to the first three groups.
Fraction # (top to bottom) Fig. 1 . Distribution of I.-[3H]pipecolic acid oxidation activity in a human liver ML fraction separated on a Percoll gradient. A human liver combined heavy and light mitochondrial (ML) fraction was fractionated on a Percoll gradient as described in the text. Individual gradient fractions were assayed for L-Pipecolic acid oxidation activity in duplicate as described in the text. Individual fractions were also assayed for glutamate dehydrogenase, a mitochondrial marker, catalase, a peroxisomal marker, and aryl esterase, a microsomal marker.
L-Pipecolic acid degradation in liver from infants with Zellweger syndrome (Cerebrohepatorenal syndrome).
We assayed L-pipecolic acid oxidation in postnuclear supernatants from human postmortem livers (Table 1) . Liver homogenates from infants with Zellweger syndrome had significantly less activity than did infant controls, adult controls, or children with X-linked adrenoleukodystrophy (p < 0.00 1). Mean activities for Zellweger syndrome infants were 3% of infant control values, 4% of adult control values, and 10% of X-linked adrenoleukodystrophy values. Catalase activity in Zellweger liver samples did not differ from that in any control group ( p > 0.2).
Liver L-pipecolic acid oxidation activity from control and from Zellweger infants is plotted against age at death in Figure 2 . Activity appears low for the first 2 wk of life in normal individuals and then attains a level comparable to that of adults. Excluding the three neonates, infant controls had mean liver activities of 63 + 9.1 pmol/mg protein/h ( n = 7). In contrast, the Zellweger infant livers always had activities less than 4 pmol/mg protein/ h, and this activity did not increase with age. Only two liver specimens from X-linked adrenoleukodystrophy patients were available. These patients, who were intermediate in age (1 1 and Age (years) Fig. 2 . Variation of 1,-pipecolic acid oxidation activity with age in liver from control infants and from infants with Zellweger syndrome. Postnuclear supernatants from frozen human liver samples were prepared and assayed as described in the text. 0, control; +, Zellweger syndrome. 13 y) between both control groups (infants older than 2 wk and adults), had less activity than either control group (p < 0.05). To determine if increased L-pipecolic acid oxidation in Zellweger syndrome resulted from liver damage, we assayed liver from one 9-mo-old infant with severe hepatic dysfunction of unknown etiology. Activity in this infant was 3 1 pmol AAA/mg protein/ h, 8.5-fold greater than the maximum in the Zellweger infants, and about half of that found in infants older than 2 wk.
DISCUSSION
In these studies, L-pipecolic acid oxidation has been assayed directly in human liver. As in the cynomolgus monkey (15, 16) , the pathway for the conversion of L-pipecolic acid to AAA in humans appears located in the peroxisome. In livers from Zellweger infants, activity is reduced more than 95%. Thus, defective peroxisomal L-pipecolic acid oxidation to AAA can explain the high circulating pipecolic acid levels in Zellweger syndrome patients.
In human liver fractionated on Percoll gradients, the distribution of L-pipecolic acid oxidation activity is most similar to that of catalase, although somewhat more diffuse (Fig. 1) 
. Our s e p a r a t i o n o f p e r o x i s o m e s f r o m m i c r o s o m e s w a s i n c o m p l e t e , as i n s o m e o t h e r s t u d i e s u s i n g self-generating Percoll g r a d i e n t s (24, 25). W e c o u l d n o t u s e o t h e r g r a d i e n t m e d i a i n these studies, s u c h as N y c o d e n z a n d M e t r i z a m i d e , because t h e y i n h i b i t e d L-pipec o l i c a c i d o x i d a t i o n u n d e r all assay c o n d i t i o n s ( d a t a n o t shown). T h e m u c h greater activity f o u n d under assay c o n d i t i o n s opti-
We w e r e c o n c e r n e d t h a t b o t h t h e d e l a y u n t i l a u t o p s y and s u b s e q u e n t l e n g t h y freezing w o u l d d e g r a d e t h e L-pipecolic a c i d o x i d a t i o n e n z y m e s . H o w e v e r , a single Zellweger liver s a m p l e , r e m o v e d i n t h e first 2-3 m i n a f t e r d e a t h , d i d n o t differ i n activity f r o m all o t h e r Zellweger samples. F u r t h e r m o r e , t h e activity i n fresh a d u l t h u m a n liver was 4 4 p m o l A A A / m g protein/h, n e a r l y identical to t h e m e a n o f 47 p m o l A A A / m g p r o t e i n / h i n f r o z e n a d u l t samples. T h u s , t h e activity seems fairly s t a b l e a f t e r r o u t i n e a u t o p s y a n d freezing at -70°C. A s o n l y 5 0 p g o f liver i s r e q u i r e d f o r triplicate assays, w e c a n p r e s u m a b l y use liver s a m p l e s obt a i n e d b y n e e d l e biopsy t o identify i n f a n t s defective i n L-pipecolic a c i d o x i d a t i o n . L-Pipecolic a c i d o x i d a t i o n a p p e a r e d l o w e r i n v e r y y o u n g inf a n t s t h a n i n o l d e r infants a n d adults. T h i s result w a s expected, as several s t u d i e s (26-28) h a v e reported pipecolic a c i d e x c r e t i o n i n n e w b o r n s . H u t z l e r and D a n c i s (27) f o u n d t h a t p l a s m a pipec o l i c a c i d levels w e r e a b o u t 2.1 pM a f t e r a g e 4 m o , w h e r e a s i n f a n t s 1 w k o r less h a d levels a v e r a g i n g 1 2 pM. I n c o n t r a s t , s e r u m pipecolic a c i d v a l u e s r a n g e s f r o m 7 to 1 8 8 pM i n Zellweger s y n d r o m e p a t i e n t s a g e d 3 mo to 3 y (29) .
A l t h o u g h Zellweger s y n d r o m e i n f a n t s h a d L-pipecolic a c i d o x i d a t i o n activities less t h a n 5 % o f control, t h e i r liver catalase activity w a s s i m i l a r to t h a t i n controls, as r e p o r t e d b y o t h e r s (6, 7 , 9, 30) . T h e s e studies c o n f i r m p r e l i m i n a r y reports that Zellweger synd r o m e i n f a n t s h a v e defective L-pipecolic a c i d o x i d a t i o n (1 5, 34). M o r e o v e r , w e f i n d t h a t t h i s activity i s p e r o x i s o m a l i n m a n a n d yields b o t h A A A and Hz02 as products. H o w e v e r , t h e origin o f t h e deleterious effects, if a n y , o f defective L-pipecolic a c i d oxid a t i o n a r e unclear. N e w b o r n i n f a n t s w i t h Zellweger s y n d r o m e h a d p l a s m a pipecolic a c i d levels s i m i l a r to those i n n o r m a l i n f a n t s (35) . A s w e c a n detect t h e e n z y m e defect i n liver f r o m y o u n g i n f a n t s w i t h Zellweger s y n d r o m e , t h e p l a c e n t a or m a t e r n a l circ u l a t i o n m a y regulate p l a s m a L-pipecolic a c i d c o n c e n t r a t i o n s d u r i n g the fetal period. I n a d d i t i o n , h y p e r l y s i n e m i c p a t i e n t s w i t h elevated pipecolic a c i d levels do n o t h a v e n e u r o l o g i c d y s f u n c t i o n (36) . These findings suggest that e l e v a t e d L-pipecolic a c i d levels per se are p r o b a b l y not t o x i c to t h e c e n t r a l n e r v o u s s y s t e m . Identification o f p a t i e n t s w i t h isolated h y p e r p i p e c o l i c a c i d u r i a s h o u l d h e l p clarify t h e pathophysiologic c o n s e q u e n c e s o f e l e v a t e d pipecolic a c i d levels.
